August 28, 2025

FDA Requests Confirmatory Evidence on Wet AMD Therapy

Outlook Therapeutics’ drug for wet age-related macular degeneration faces an FDA approval setback.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

August 25, 2025

What Does Xlear’s Lawsuit Mean for Physicians?

Xlear's xylitol maker sues the FTC to loosen evidence rules on health claims, signaling a deregulatory push that could reshape supplement marketing.

KFF Health News

August 22, 2025

Protease Activator Approved by the FDA for Diffuse Midline Glioma

This represents the first FDA approval of a systemic therapy for H3 K27M–mutant diffuse midline glioma.

The ASCO Post

August 21, 2025

FDA Grants RMAT to VeonGen Gene Therapy

VG801 is being developed for Stargardt disease and other ABCA4-related retinal disorders.

Retinal Physician

August 19, 2025

Bedtime Cyclobenzaprine Relieves Fibromyalgia: Randomized Trial

Researchers found bedtime sublingual cyclobenzaprine reduced pain versus placebo and improved sleep, fatigue, and function with mostly mild oral adverse events.

Conexiant

August 18, 2025

FDA Approves New Indication for Wegovy

Accelerated approval granted to Wegovy for treatment of noncirrhotic metabolic dysfunction–associated steatohepatitis in adults with stage F2 to F3 fibrosis.

Conexiant

August 18, 2025

US Vaccine Panels: Conflict and Recusal Trends

Reported conflicts of interest in US vaccine advisory panels have dropped to historically low levels.

Conexiant